Serum phosphorus management with sucroferric oxyhydroxide as a first-line phosphate binder within the first year of hemodialysis

CONCLUSIONS: Among patients on hemodialysis, initiating SO as a first-line PB resulted in significant reductions in sP while maintaining a relatively low PB pill burden.PMID:38091973 | DOI:10.1159/000535754
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Source Type: research